Alcendor Donald J
Center for AIDS Health Disparities Research, Meharry Medical College, 1005 Dr. D.B. Todd Jr. Blvd., Hubbard Hospital, 5th Floor, Rm. 5025, Nashville, TN 37208, USA.
J Clin Med. 2019 Sep 17;8(9):1477. doi: 10.3390/jcm8091477.
BK polyomavirus (BKPyV), or BKV infection, is ubiquitous and usually non-pathogenic, with subclinical infections in 80-90% of adults worldwide. BKV infection is often associated with pathology in immunocompromised individuals. BKV infection often is associated with renal impairment, including ureteral stenosis, hemorrhagic cystitis, and nephropathy. BKV infection is less commonly associated with pneumonitis, retinitis, liver disease, and meningoencephalitis. BKV is known to replicate, establish latency, undergo reactivation, and induce clinical pathology in renal tubular epithelial cells. However, recent in vitro studies support the notion that BKV has expanded tropism-targeting glomerular parenchymal cells of the human kidney, which could impact glomerular function, enhance inflammation, and serve as viral reservoirs for reactivation from latency during immunosuppression. The implications of BKV expanded tropism in the glomerulus, and how specific host and viral factors that would contribute to glomerular inflammation, cytolysis, and renal fibrosis are related to BKV associated nephropathy (BKVAN), have not been explored. The pathogenesis of BKV in human glomerular parenchymal cells is poorly understood. In this review, I examine target cell populations for BKV infectivity in the human glomerulus. Specifically, I explore the implications of BKV expanded tropism in the glomerulus with regard viral entry, replication, and dissemination via cell types exposed to BKV trafficking in glomerulus. I also describe cellular targets shown to be permissive in vitro and in vivo for BKV infection and lytic replication, the potential role that glomerular parenchymal cells play in BKV latency and/or reactivation after immunosuppression, and the rare occurrence of BKV pathology in glomerular parenchymal cells in patients with BKVAN.
BK多瘤病毒(BKPyV)感染十分普遍,通常无致病性,全球80-90%的成年人存在亚临床感染。BKPyV感染常与免疫功能低下个体的病变相关。BKPyV感染常与肾功能损害有关,包括输尿管狭窄、出血性膀胱炎和肾病。BKPyV感染较少与肺炎、视网膜炎、肝病和脑膜脑炎相关。已知BKPyV可在肾小管上皮细胞中复制、建立潜伏状态、重新激活并诱发临床病理。然而,最近的体外研究支持了这样一种观点,即BKPyV具有扩大的嗜性,可靶向人类肾脏的肾小球实质细胞,这可能影响肾小球功能、加剧炎症,并在免疫抑制期间作为潜伏状态重新激活的病毒储存库。BKPyV在肾小球中嗜性扩大的影响,以及导致肾小球炎症、细胞溶解和肾纤维化的特定宿主和病毒因素与BK多瘤病毒相关性肾病(BKVAN)的关系尚未得到探索。BKPyV在人类肾小球实质细胞中的发病机制尚不清楚。在这篇综述中,我研究了BKPyV在人类肾小球中的感染靶细胞群体。具体而言,我探讨了BKPyV在肾小球中嗜性扩大对病毒通过肾小球中暴露于BKPyV转运的细胞类型进入、复制和传播的影响。我还描述了在体外和体内对BKPyV感染和裂解复制具有易感性的细胞靶点、肾小球实质细胞在免疫抑制后BKPyV潜伏和/或重新激活中可能发挥的作用,以及BKVAN患者肾小球实质细胞中BKPyV病理的罕见发生情况。